Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 2.63 is 51% below its 5-year average of 5.41, near the low end of its 5-year range (0.71–13.28).
As of the fiscal period ended Tuesday, June 30, 2026. 1.66% below its 12-month average of 2.67.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.63.
CURRENT RATIO
2.63
CURRENT RATIO AVG TTM
2.67
CURRENT RATIO AVG 3Y
3.43
CURRENT RATIO AVG 5Y
5.41
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-1.66%
CURRENT VS 3Y AVG
-23.44%
CURRENT VS 5Y AVG
-51.42%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.40
median of 624 covered companies
CURRENT VS SECTOR MEDIAN
-22.56%
vs the sector median at left
Market Cap
$7.33M
Current Ratio
1.37
TTM Avg
4.18
3Y Avg
4.61
5Y Avg
4.18
Market Cap
$7.23M
Current Ratio
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$7.83M
Current Ratio
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Longeveron Inc. (LGVN) | $7.33M | 2.63 | 2.67 | 3.43 | 5.41 |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.33M | 1.37 | 4.18 | 4.61 | 4.18 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.23M | 45.95 | 58.73 | 40.89 | 40.89 |
| KALA BIO, Inc. (KALA)vs › | $7.22M | 6.88 | 3.46 | 4.15 | 4.60 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.01M | 0.18 | 0.90 | 2.08 | 1.78 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.83M | 5.86 | 2.71 | 2.06 | 3.31 |
| GT Biopharma, Inc. (GTBP)vs › | $7.91M | 2.61 | 2.11 | 2.42 | 2.17 |
| HeartSciences Inc. (HSCS)vs › | $7.98M | 0.12 | 0.56 | 1.70 | 1.47 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.07M | 1.81 | 4.14 | 10.76 | 11.50 |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.96M | 7.10 | 3.48 | 3.83 | 5.25 |
Current Ratio
2.63
Quick Ratio
2.63
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 2.63 |
| 2026-03-31 | 3.88 |
| 2025-12-31 | 1.33 |
| 2025-09-30 | 2.09 |
| 2025-06-30 | 3.43 |
| 2025-03-31 | 5.61 |
| 2024-12-31 | 7.60 |
| 2024-09-30 | 7.67 |
| 2024-06-30 | 4.18 |
| 2024-03-31 | 0.71 |
| 2023-12-31 | 1.50 |
| 2023-09-30 | 1.49 |
| 2023-06-30 | 2.52 |
| 2023-03-31 | 4.14 |
| 2022-12-31 | 4.17 |
| 2022-09-30 | 6.25 |
| 2022-06-30 | 7.80 |
| 2022-03-31 | 13.28 |
| 2021-12-31 | 13.06 |
| 2021-09-30 | 10.18 |
| 2021-06-30 | 10.12 |
| 2021-03-31 | 9.10 |
| 2020-12-31 | 0.48 |
| 2020-09-30 | 0.76 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.95 |
